Significados de erythropoiesis-stimulating agent en inglés

Hyporesponsiveness to erythropoiesis-stimulating agent therapy in dialysis patients is poorly understood.

The toxicological effects included the exaggerated pharmacology and secondary sequelae that resulted from an erythropoiesis-stimulating agent treatment to healthy animals.

The strength of this association was attenuated more by adjustment for malnutrition and inflammation than by IV iron and erythropoiesis-stimulating agent dose in each region.